Trial Profile
A Study Evaluating Impact of Abiraterone Acetate on Circulating Neuromediators in Chemotherapy Naive Castration Resistant Prostate Cancer Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 14 Dec 2016 New trial record